AKORN FDA Approval ANDA 202916

ANDA 202916

AKORN

FDA Drug Application

Application #202916

Documents

Letter2013-11-20

Application Sponsors

ANDA 202916AKORN

Marketing Status

Prescription001

Application Products

001SOLUTION/DROPS;OPHTHALMICEQ 0.5% BASE0MOXIFLOXACIN HYDROCHLORIDEMOXIFLOXACIN HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP2017-11-09

Submissions Property Types

ORIG1Null42

TE Codes

001PrescriptionAT1

CDER Filings

AKORN
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202916
            [companyName] => AKORN
            [docInserts] => ["",""]
            [products] => [{"drugName":"MOXIFLOXACIN HYDROCHLORIDE","activeIngredients":"MOXIFLOXACIN HYDROCHLORIDE","strength":"EQ 0.5% BASE","dosageForm":"SOLUTION\/DROPS;OPHTHALMIC","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"11\/09\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2013\\\/202916Orig1s000TAltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-11-09
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.